Meloxicam

Product NDC: 68462-141
11-digit product format: 684620141
Labeler code: 68462
Product ID: 68462-141_1bfddea3-c305-4688-978d-36c882261be7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Meloxicam
Dosage form: TABLET
Route: ORAL
Labeler: Glenmark Pharmaceuticals Inc., USA
Application: ANDA077932
Marketing category: ANDA
Marketing start: 2021-06-01
Marketing end: 0000-00-00
Substance: MELOXICAM
Active strength: 15 mg/1
Pharmacologic classes: Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68462-141		D	Discontinued by firm		2026-10-15
excluded package	package	68462-141	68462-141-01	D	Discontinued by firm		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 4 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68462-141-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68462-141-01	`f5e01cc5f278…`	`a2eaf40c39c3…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077932-001	MELOXICAM	MELOXICAM	7.5MG	TABLET / ORAL	AB		2006-07-19
A077932-002	MELOXICAM	MELOXICAM	15MG	TABLET / ORAL	AB		2006-07-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A077932-001	AB
A077932-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077932-001	MELOXICAM	7.5MG	TABLET / ORAL	AB	2006-07-19	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077932-002	MELOXICAM	15MG	TABLET / ORAL	AB	2006-07-19	`4b0b4de00fa7…`

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A077932-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077932-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077932-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077932-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077932-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A077932-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077932-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077932-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077932-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A077932-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077932-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A077932-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077932-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A077932-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077932-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077932-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077932-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077932-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077932-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077932-002	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077932-001	AB	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A077932-002	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A077932-001	AB	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A077932-002	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A077932-001	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A077932-002	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077932-001	AB	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A077932-002	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077932-001	AB	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A077932-002	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077932-001	AB	1	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A077932-002	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077932-001	AB	1	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A077932-002	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A077932-001	AB	1	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	A077932-002	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A077932-001	AB	1	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	A077932-002	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077932-001	AB	1	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A077932-002	AB	1	`3a93d1ddd44b…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
68462-141-01	EA - Each	68462-141	915328c2-afd1-40bb-a82f-dc85ac33a268	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
MELOXICAM	ACTIVE INGREDIENT	VG2QF83CGL	MELOXICAM TABLET [GLENMARK GENERICS INC., USA]	5
MELOXICAM	ACTIVE MOIETY	VG2QF83CGL	MELOXICAM TABLET [GLENMARK GENERICS INC., USA]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MELOXICAM TABLET [GLENMARK GENERICS INC., USA]	5
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	MELOXICAM TABLET [GLENMARK GENERICS INC., USA]	5
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	MELOXICAM TABLET [GLENMARK GENERICS INC., USA]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MELOXICAM TABLET [GLENMARK GENERICS INC., USA]	5
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	MELOXICAM TABLET [GLENMARK GENERICS INC., USA]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	MELOXICAM TABLET [GLENMARK GENERICS INC., USA]	5
TRISODIUM CITRATE DIHYDRATE	INACTIVE INGREDIENT	B22547B95K	MELOXICAM TABLET [GLENMARK GENERICS INC., USA]	5

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
VG2QF83CGL	MELOXICAM	71125-38-7	MELOXICAM

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68462-141-01	68462014101	100 TABLET in 1 BOTTLE (68462-141-01)	100 tablet	2021-06-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Meloxicam	Glenmark Pharmaceuticals Inc., USA \| Glenmark Pharmaceuticals Limited	2024-08-07	HUMAN PRESCRIPTION DRUG LABEL	11